NEUROLOGY 1992;42:545
© 1992 American Academy of Neurology
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)
A correlative study of the clinical features and mitochondrial DNA mutation
Y. Goto, MD,
S. Horai, MD,
T. Matsuoka, MD,
Y. Koga, MD,
K. Nihei, MD,
M. Kobayashi, MD and
I. Nonaka, MD
Division of Ultrastructural Research, National Institute of Neuroscience, NCNP, Kodaira, Tokyo, Japan (Drs. Goto, Matsuoka, Koga, and Nonaka)
Department of Human Genetics, National Institute of Genetics, Mishima, Japan (Dr. Horai)
Department of Neurology, National Children's Hospital, Tokyo, Japan (Dr. Nihei)
Department of Pediatrics, Nagoya City University, Nagoya, Japan (Dr. Kobayashi).
We studied 40 MELAS patients (21 male and 19 female) to characterize the clinical features and biochemical and muscle biopsy findings related to the mtDNA mutation at the nucleotide position of 3,243, the most common genetic defect in MELAS. The most frequent symptom was episodic sudden headache with vomiting and convulsions, which commonly affected patients aged 5 to 15 years (80%). Biochemical defects in the muscle were variable; 13 patients had complex I, seven complex IV, and four complexes I+IV deficiencies. In four muscle biopsies without ragged-red fibers or any enzyme defect, we based the diagnosis on the identification of strongly SDH-reactive blood vessels, which occurred in 87.5% of the biopsies. The mtDNA mutation was present in 32 of 40 patients (80%). We conclude that there are no clinical and pathologic differences between the patients with and without this mtDNA mutation.
Address correspondence and reprint requests to Dr. Yu-ichi Goto, Division of Ultrastructural Research, National Institute of Neuroscience, NCNP, 411 Ogawahigashi, Kodaira, Tokyo 187, Japan.
Received April 16, 1991. Accepted for publication in final form August 2, 1991.
This article has been cited by other articles:

|
 |

|
 |
 
F. D. Testai and P. B. Gorelick
Inherited Metabolic Disorders and Stroke Part 1: Fabry Disease and Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes
Arch Neurol,
January 1, 2010;
67(1):
19 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Ju Seok Ryu, Sook Joung Lee, In Young Sung, Tae Sung Ko, and Han Ik Yoo
Depressive Episode With Catatonic Features in a Case of Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)
J Child Neurol,
October 1, 2009;
24(10):
1307 - 1309.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Francione, P. K. Smith, S. L. Accari, P. E. Taylor, P. B. Bokko, S. Bozzaro, P. L. Beech, and P. R. Fisher
Legionella pneumophila multiplication is enhanced by chronic AMPK signalling in mitochondrially diseased Dictyostelium cells
Dis. Model. Mech.,
September 1, 2009;
2(9-10):
479 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. McKenzie, D. Liolitsa, N. Akinshina, M. Campanella, S. Sisodiya, I. Hargreaves, N. Nirmalananthan, M. G. Sweeney, P. M. Abou-Sleiman, N. W. Wood, et al.
Mitochondrial ND5 Gene Variation Associated with Encephalomyopathy and Mitochondrial ATP Consumption
J. Biol. Chem.,
December 21, 2007;
282(51):
36845 - 36852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kervinen, R. Hinttala, H. M. Helander, S. Kurki, J. Uusimaa, M. Finel, K. Majamaa, and I. E. Hassinen
The MELAS mutations 3946 and 3949 perturb the critical structure in a conserved loop of the ND1 subunit of mitochondrial complex I
Hum. Mol. Genet.,
September 1, 2006;
15(17):
2543 - 2552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Sparaco, M Feleppa, R. Lipton, A. Rapoport, and M. Bigal
Mitochondrial Dysfunction and Migraine: Evidence and Hypotheses
Cephalalgia,
April 1, 2006;
26(4):
361 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kirino, Y.-i. Goto, Y. Campos, J. Arenas, and T. Suzuki
Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease
PNAS,
May 17, 2005;
102(20):
7127 - 7132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Baba, D. F. Broderick, R. J. Uitti, M. L. Hutton, and Z. K. Wszolek
Heredofamilial Brain Calcinosis Syndrome
Mayo Clin. Proc.,
May 1, 2005;
80(5):
641 - 651.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. H. Tay, S. Shanske, C. Crowe, A. Shanske, I. Schafer, J. Pancrudo, Jiesheng Lu, E. Bonilla, and S. DiMauro
Clinical and Genetic Features in Two Families With MELAS and the T3271C Mutation in Mitochondrial DNA
J Child Neurol,
February 1, 2005;
20(2):
142 - 146.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kirino, T. Yasukawa, S. Ohta, S. Akira, K. Ishihara, K. Watanabe, and T. Suzuki
Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease
PNAS,
October 19, 2004;
101(42):
15070 - 15075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Remes, E. V. Liimatta, S. Winqvist, U. Tolonen, J. A. Ranua, K. Reinikainen, I. E. Hassinen, and K. Majamaa
Ubiquinone and nicotinamide treatment of patients with the 3243A->G mtDNA mutation
Neurology,
October 22, 2002;
59(8):
1275 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Brown and D. A. Clayton
Release of replication termination controls mitochondrial DNA copy number after depletion with 2',3'-dideoxycytidine
Nucleic Acids Res.,
May 1, 2002;
30(9):
2004 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Spellberg, R. M. Carroll, E. Robinson, and E. Brass
mtDNA Disease in the Primary Care Setting
Arch Intern Med,
November 12, 2001;
161(20):
2497 - 2500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yonemura, Y. Hasegawa, K. Kimura, K. Minematsu, and T. Yamaguchi
Diffusion-weighted MR Imaging in a Case of Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes
AJNR Am. J. Neuroradiol.,
February 1, 2001;
22(2):
269 - 272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zhong, M. C Y Ng, Y M D. Lo, J. C N Chan, and P. J Johnson
Presence of mitochondrial tRNA Leu(UUR) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus
J. Clin. Pathol.,
June 1, 2000;
53(6):
466 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Uusimaa, A. M. Remes, H. Rantala, L. Vainionpaa, R. Herva, K. Vuopala, M. Nuutinen, K. Majamaa, and I. E. Hassinen
Childhood Encephalopathies and Myopathies: A Prospective Study in a Defined Population to Assess the Frequency of Mitochondrial Disorders
Pediatrics,
March 1, 2000;
105(3):
598 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Sharfstein, M. F. Gordon, R. B. Libman, and E. S. Malkin
Adult-Onset MELAS Presenting as Herpes Encephalitis
Arch Neurol,
February 1, 1999;
56(2):
241 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Haan, G. Terwindt, J. Maassen, L. Hart, R. Frants, and M. Ferrari
Search for Mitochondrial Dna Mutations in Migraine Subgroups
Cephalalgia,
January 1, 1999;
19(1):
20 - 22.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Dashe and P. J. Boyer
Case 39-1998- A 13-Year-Old Girl with a Relapsing-Remitting Neurological Disorder
N. Engl. J. Med.,
December 24, 1998;
339(26):
1914 - 1923.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Kimata, L. Gordan, E. T. Ajax, P. H. Davis, and T. Grabowski
A Case of Late-Onset MELAS
Arch Neurol,
May 1, 1998;
55(5):
722 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Gilchrist, M. Sikirica, E. Stopa, and S. Shanske
Adult-Onset MELAS: Evidence for Involvement of Neurons as Well as Cerebral Vasculature in Strokelike Episodes
Stroke,
August 1, 1996;
27(8):
1420 - 1423.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. R. Riela and E. S. Roach
Topical Review Article: Etiology of Stroke in Children
J Child Neurol,
July 1, 1993;
8(3):
201 - 220.
[Abstract]
[PDF]
|
 |
|
|